Eli Lilly and Company and Avid Radiopharmaceuticals have announced the approval of Amyvid (Florbetapir (18F)) solution for injection in European Union to detect the beta-amyloid neuritic plaque density in patients with cognitive impairment ...
Tags: diagnostic radiopharmaceutical, Eli Lilly Amyvid, disease
NorthShore University HealthSystem has used Amyvid (Florbetapir F 18 Injection) radioactive diagnostic agent to evaluate patients for Alzheimer's disease. The diagnostic agent, approved for positron emission tomography (PET) imaging ...
Tags: clinical trial, Alzheimer's disease, positron emission tomography
Cardinal Health has entered into an agreement to manufacture and distribute Eli Lilly and Company's new diagnostic imaging agent, Amyvid, at seven sites throughout the US. Amyvid, a radioactive diagnostic agent, tagged with a ...
Eli Lilly and Company and Avid Radiopharmaceuticals have gained positive CHMP opinion for Amyvid (Florbetapir F 18 injection) for the use as a diagnostic tool for positron emission tomography (PET) imaging of beta-amyloid plaque density in ...
Tags: Amyvid, Positive CHMP Opinion, Cognitive Impairment Diagnosis